HPV-RELATED MALIGNANCY
Clinical trials for HPV-RELATED MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED MALIGNANCY trials appear
Sign up with your email to follow new studies for HPV-RELATED MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune therapy aims to tackle HPV cancers before standard care
Disease control Recruiting nowThis study tests whether a single infusion of a patient's own genetically engineered immune cells (E7 TCR-T cells) can shrink or eliminate HPV-related cancers before the patient receives standard treatment like chemo-radiation or surgery. The trial enrolls 15 adults with advanced…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers, such as cervical, throat, anal, and penile cancers. Participants receive specially engineered immune cells designed to attack cancer cells carrying the HPV16 virus. The goal is to see if this treat…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo aims to outsmart Drug-Resistant cervical cancer
Disease control Recruiting nowThis phase 2 study is testing whether adding an experimental therapy called PRGN-2009 to the immunotherapy drug pembrolizumab can help shrink tumors in people with recurrent or metastatic cervical cancer that has stopped responding to pembrolizumab alone. About 24 adults with HPV…
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test may help some throat cancer patients skip or shorten radiation
Disease control Recruiting nowThis study is testing whether a blood test that detects HPV DNA can help doctors decide who needs radiation after surgery for HPV-related oropharynx cancer. In one group, patients with no detectable HPV DNA after surgery will be watched closely and only get radiation if the test …
Matched conditions: HPV-RELATED MALIGNANCY
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC